Galecto inc.

Major-Pharmaceuticals

GLTO


75 State Street
Boston , MA 02109

Executive/
Director

Price

  • Last Close
  • $ 0.44
    $ -0.09 -16.98 %
    Aug 29, 2024
  • 52-Week High/Low
  • $0.89 - $0.44
  • YTD
  • -38.9%

  • Trading Volume
  • 127,304
  • Market Cap Full
  • $ 11.9M
  • Shares Outstanding
  • 27.1M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - -5% -51.9% -27.4% 73% 8.3%
Q2 - - - - - 4% -16.7% -21.4% 26.6% 2.7%
Q3 - - - - - 8% -29.3% 9.3% -71.4% -
Q4 - - - - - -15.9% -15.4% -39.2% 7.5% -
J F M A M J J A S O N D
2024 -13.8% 15.9% 8.3% -1.9% - - - - - - - -
2023 100% -4.8% -9.1% -11.6% 23.9% 15.6% 22.2% -80.4% 19% -26.4% 18.9% 14.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%-76%-62%-37%-39%

Earnings

2021 2022 2023
Q1 -0.53 -0.67 -0.51
Q2 -0.49 -0.67 -0.41
Q3 -0.5 -0.54 -0.30
Q4 -0.53 -0.55 -
A -2.1 -2.4 -1.22

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 25.3 25.3 25.7
Jun - 25.3 25.3 25.7
Sep - 25.3 25.4 27.1
Dec 25.3 25.3 25.6 27.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -61 - -34 19.5 -
Equity multiplier 0.1 0.1 - - -